ETF:REVS | ETF Holdings Page 4 | Columbia Research Enhanced Value ETF

REVS ETF holdings Page 4

Weights reproduce the dated portfolio and may not sum to exactly 100% because of cash, derivatives, rounding, liabilities, or other positions. Provenance stays internal.

Snapshot fieldReported value
FundColumbia Research Enhanced Value ETF
Report date2026-04-30
Reported holdings310
SEC series IDS000066077

Positions 301–310 of 310

TickerIssuerWeightValue (USD)Balance
NBIXNeurocrine Biosciences Inc0.005013%14,220.36108 NS
INSMInsmed Inc0.004517%12,815.0294 NS
PCTYPaylocity Holding Corp0.004202%11,920.37113 NS
DVDoubleVerify Holdings Inc0.003096%8,782.94797 NS
CAICaris Life Sciences Inc0.002471%7,011369 NS
IONSIonis Pharmaceuticals Inc0.002293%6,504.1287 NS
CONTRA WALGREENS BOOTSCONTRA WALGREENS BOOTS0.002032%5,76511,530 NS
SRPTSarepta Therapeutics Inc0.000949%2,693.52129 NS
CONTRA HOLOGIC INCORPOCONTRA HOLOGIC INCORPO0.000032%91.539,153 NS
CONTRA MIRATI THERAPEUCONTRA MIRATI THERAPEU0.000009%25.551 NS

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.